Kids Library Home

Welcome to the Kids' Library!

Search for books, movies, music, magazines, and more.

Back to Search Results
     
Available items only
Previous Record Next Record
E-Book/E-Doc

Title Guidance for industry [electronic resource] : S7B nonclinical evaluation of the potential for delayed ventricular repolarization (QT Interval Prolongation) by human pharmaceuticals.

Imprint Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [2005]
Connect to
Connect to https://permanent.fdlp.gov/LPS113878/LPS113878/www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm129122.pdf

Copies

Location Call No. OPAC Message Status
 Axe Federal Documents Online  HE 20.4702:N 73/2    ---  Available
Description 10 p. : digital, PDF file
System Details Mode of access via the FDA web site.
Note Title from PDF title page (viewed on June 19th, 2009).
"ICH".
"October 2005".
Subject Heart -- Ventricles.
Palpitation.
Drugs -- Testing.
Added Author Center for Drug Evaluation and Research (U.S.)
Center for Biologics Evaluation and Research (U.S.)
International Conference on Harmonisation.
Added Title S7B nonclinical evaluation of the potential for delayed ventricular repolarization (QT Interval Prolongation) by human pharmaceuticals
Nonclinical evaluation of the potential for delayed ventricular repolarization (QT Interval Prolongation) by human pharmaceuticals
Gpo Item No. 0499-T (online)
Sudoc No. HE 20.4702:N 73/2

 
    
Available items only